Literature DB >> 3797169

Is chronic lung disease in low birth weight infants preventable? A survey of eight centers.

M E Avery, W H Tooley, J B Keller, S S Hurd, M H Bryan, R B Cotton, M F Epstein, P M Fitzhardinge, C B Hansen, T N Hansen.   

Abstract

Chronic lung disease in prematurely born infants, defined as the need for increased inspired oxygen at 28 days of age, was thought to be more common in some institutions than in others. To test this hypothesis, we surveyed the experience in the intensive care nurseries at Columbia and Vanderbilt Universities, the Universities of Texas at Dallas, Washington at Seattle, and California at San Francisco, the Brigham and Women's Hospital in Boston, Texas Children's Hospital in Houston, and Mt Sinai Hospital in Toronto. The survey included 1,625 infants with birth weights of 700 to 1,500 g. We confirmed the relationship of risk to low birth weight, white race, and male sex. Significant differences in the incidence of chronic lung disease were found between institutions even when birth weight, race, and sex were taken into consideration through a multivariate logistic regression analysis. Columbia had one of the best outcomes for low birth weight infants and the lowest incidence of chronic lung disease.

Entities:  

Mesh:

Year:  1987        PMID: 3797169

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  136 in total

Review 1.  Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).

Authors:  E Eber; M S Zach
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

Review 2.  Current perspectives on the drug treatment of neonatal respiratory distress syndrome.

Authors:  D G Sweet; H L Halliday
Journal:  Paediatr Drugs       Date:  1999 Jan-Mar       Impact factor: 3.022

3.  Factors affecting the incidence of chronic lung disease of prematurity in 1987, 1992, and 1997.

Authors:  B N Manktelow; E S Draper; S Annamalai; D Field
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-07       Impact factor: 5.747

4.  Events before the diagnosis of a pneumothorax in ventilated neonates.

Authors:  M Watkinson; I Tiron
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-11       Impact factor: 5.747

Review 5.  Nasal CPAP for neonates: what do we know in 2003?

Authors:  A G De Paoli; C Morley; P G Davis
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

6.  Prevention of bronchopulmonary dysplasia: current strategies.

Authors:  Deepak Jain; Eduardo Bancalari
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-08

Review 7.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

8.  Minimal handling and bronchopulmonary dysplasia in extremely low-birth-weight infants.

Authors:  G Latini; C De Felice; G Presta; E Rosati; P Vacca
Journal:  Eur J Pediatr       Date:  2003-02-07       Impact factor: 3.183

9.  Development of audit measures and guidelines for good practice in the management of neonatal respiratory distress syndrome. Report of a Joint Working Group of the British Association of Perinatal Medicine and the Research Unit of the Royal College of Physicians.

Authors: 
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

Review 10.  How has research in the past 5 years changed my clinical practice.

Authors:  Anne Greenough
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-09       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.